Oral formulations are designed to survive the stomach acid and are better suited for addressing systemic inflammation and gastrointestinal issues like ulcers or inflammatory bowel disease
Nausea is the most common side-effect GLP-1 symptom, followed by vomiting, sour burps, heartburn and gastroparesis Side-Effect Profile of GLP-1s, from Worst to Best (% reflects estimated number of patients with GI side-effects) 50% Semaglutide (Ozempic, Rybelsus, Wegovy) 40% Tirzepatide (Saxenda, Mounjaro) 40% Liraglutide (Victoza, Saxenda) 30% Lixisenatide (Adlyxin USA, Lyxumia UK) 10% Dulaglutide (Trulicity) 10% Exenatide (Byetta, Bydureon) Wegovy, Mounjaro, and Saxenda FDA-approved for weight loss
Rotacin de sitios de inyeccin: Alternar entre abdomen, muslo y brazo (segn las indicaciones del medicamento especfico) previene lipodistrofia y reacciones locales, independientemente del horario elegido
Improves skin texture
Data were obtained by flow cytometry (NovoCyte3000, Agilent, USA) and analyzed using FlowJo V10 software